Trial record 75 of 350 for:
Gastrointestinal Stromal Tumors
MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01991379 |
Recruitment Status :
Active, not recruiting
First Posted : November 25, 2013
Last Update Posted : December 4, 2023
|
Sponsor:
Memorial Sloan Kettering Cancer Center
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | November 2024 |
Estimated Study Completion Date : | November 2024 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):